Table 3.
Serum biomarkers between the PPF-ASS and non-PPF-ASS groups
| Total (n = 72) | PPF-ASS (n = 18) | Non-PPF-ASS (n = 54) | χ2/t | p | |
|---|---|---|---|---|---|
| KL-6, U/mL | 820.9 ± 300.9 | 1009.3 ± 382.0 | 758.0 ± 241.7 | N/A | 0.011* |
| GDF-15, pg/mL | 221.5 ± 91.7 | 226.8 ± 102.5 | 219.7 ± 88.8 | 0.408 | 0.778 |
| Wnt-5a, ng/mL | 3.1 ± 4.0 | 3.6 ± 4.7 | 3.0 ± 3.7 | N/A | 0.607 |
Data are presented as the mean ± SD or n (%)
ASS anti-synthetase syndrome, GDF-15 growth differentiation factor 15, KL-6 Krebs von den Lungen-6, N/A not applicable, PPF progressive pulmonary fibrosis, Wnt wingless
*p < 0.05